Oxford BioDynamics (United Kingdom)
For the first time, a simple blood test reliably identifies Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). In development, EpiSwitch ME/CFS demonstrated 96% accuracy in detecting the condition. For the millions of patients worldwide who have faced years of uncertainty, misdiagnosis, or dismissal with this often-debilitating illness, EpiSwitch ME/CFS offers hope for faster, more reliable diagnosis.
Basic Information
- Category: business
- Website: https://www.oxfordbiodynamics.com
Documented Facts
- Phone: 967-025-0720 (No linked source recorded for this statement.)
Evidence and Sources
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Oxford BioDynamics (United Kingdom).
- Canonical profile: https://brandsource.ai/brands/oxford-biodynamics-united-kingdom
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/oxford-biodynamics-united-kingdom/json-ld
- Citation profile API: https://brandsource.ai/api/brands/oxford-biodynamics-united-kingdom/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (85/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
For the first time, a simple blood test reliably identifies Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). In development, EpiSwitch ME/CFS demonstrated 96% accuracy in detecting the condition. For the millions of patients worldwide who have faced years of uncertainty, misdiagnosis, or dismissal with this often-debilitating illness, EpiSwitch ME/CFS offers hope for faster, more reliable diagnosis.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 3 supporting sources linked.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.